dea
dea · page 3
- Uncategorized
DEA Under Fire: New Documents Provide Evidence of DEA’s Bias in Rescheduling Process
New court documents are said to provide new evidence of the US Drug Enforcement Administration’s bias against cannabis rescheduling, a process which it is overseeing.
- Uncategorized
DOJ Ruling on Judge Protections Could Accelerate Cannabis Research Lawsuit Against DEA
The US Department of Justice (DOJ) has determined that protections preventing the removal of Administrative Law Judges (ALJs) are unconstitutional and will no longer defend them in court, a move that could have significant implications for cannabis research.
- Uncategorized
DEA Faces Another Lawsuit Over Handling of Cannabis Rescheduling
The US Drug Enforcement Administration (DEA) is facing another legal challenge over its handling of the cannabis rescheduling process.
- Uncategorized
CRS Research Says Cannabis Rescheduling Future ‘Unclear’ as Legal Challenges Emerge
This week has seen another frenetic torrent of executive orders issued by the newly inaugurated President Trump, causing chaos across almost all of America’s cornerstone institutions.
- Uncategorized
Poll Shows 96% of Cannabis Consumers Distrust DEA’s Role in Rescheduling Debate
Two weeks after the shock suspension of proceedings in the landmark cannabis rescheduling process, it appears the US public believes it was the correct choice.
- Uncategorized
Cannabis Rescheduling Feared ‘Dead’ Following Appointment of New DEA Administrator Maltz
Cannabis rescheduling was dealt a major blow today as it was confirmed that long-time cannabis sceptic and anti-drug veteran Derek S. Maltz has been appointed as acting administrator of the DEA.
- Uncategorized
What’s Next For Cannabis Rescheduling After Shock Delay?
The rescheduling of cannabis in the US, one of the most consequential cannabis reform efforts of the last century, is on increasingly uncertain ground amid a shock postponement and the introduction of a new enigmatic administration.
- Uncategorized
Cannabis Rescheduling Hearing Delayed Amid Escalation of Tensions Between DEA and Other Witnesses
The highly anticipated hearings on cannabis rescheduling, set to begin next week, have now been cancelled in a major escalation of tensions between the Drug Enforcement Administration (DEA) and other witnesses.
- Uncategorized
Cannabis Stocks Fall as DEA Ordered to Respond to Bias Allegations
Cannabis stocks plummeted this week after a judge ordered the Drug Enforcement Agency (DEA) to respond to damning new allegations that it is working to undermine the cannabis rescheduling process.
- Cultivation
Immediate Investigation into DEA’s Conduct Demanded Ahead of Rescheduling Hearings Amid Fresh Allegations of Bias
The Drug Enforcement Administration (DEA) has come under renewed pressure to be removed from the upcoming cannabis rescheduling process amid fresh allegations of bias.
- Uncategorized
DEA Requests Subpoenas to ‘Compel’ FDA Experts to Give Testimony on Cannabis Rescheduling, Amid Accusations It Is Trying to Overwhelm the Process
The US Drug Enforcement Administration (DEA) has formally requested that the Food and Drug Administration be ‘compelled’ by the court to give evidence at the upcoming cannabis rescheduling hearings.
- Uncategorized
Cannabis Rescheduling Hearing Set to Begin on January 21 for 6 Weeks, As Frustrations Over Process Continue to Build
The Drug Enforcement Administration (DEA) has scheduled an official date for the highly anticipated public hearing on cannabis rescheduling, starting with a presentation from the government just a day after President Elect Donald Trump is sworn in.
